BioSig Technologies, Inc. (BSGM)
USD 0.49
(-2.65%)
USD 0.49
(-2.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -29.04 Million USD | -6.49% |
| 2022 | -27.27 Million USD | 13.04% |
| 2021 | -31.36 Million USD | 39.89% |
| 2020 | -52.17 Million USD | -53.81% |
| 2019 | -33.92 Million USD | -96.63% |
| 2018 | -17.25 Million USD | -35.88% |
| 2017 | -12.69 Million USD | -9.57% |
| 2016 | -11.58 Million USD | -22.47% |
| 2015 | -9.46 Million USD | -11.67% |
| 2014 | -8.47 Million USD | 13.58% |
| 2013 | -9.8 Million USD | -295.83% |
| 2012 | -2.47 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.91 Million USD | -15.17% |
| 2024 Q1 | -3.4 Million USD | 43.76% |
| 2023 FY | -29.04 Million USD | -6.49% |
| 2023 Q2 | -11.09 Million USD | -51.3% |
| 2023 Q3 | -4.56 Million USD | 58.81% |
| 2023 Q4 | -6.04 Million USD | -32.39% |
| 2023 Q1 | -7.33 Million USD | -4.67% |
| 2022 Q2 | -5.75 Million USD | 27.68% |
| 2022 Q1 | -7.96 Million USD | 7.88% |
| 2022 Q4 | -7 Million USD | -9.93% |
| 2022 Q3 | -6.37 Million USD | -10.64% |
| 2022 FY | -27.27 Million USD | 13.04% |
| 2021 Q2 | -7.7 Million USD | 7.43% |
| 2021 FY | -31.36 Million USD | 39.89% |
| 2021 Q3 | -7.25 Million USD | 5.82% |
| 2021 Q4 | -8.64 Million USD | -19.18% |
| 2021 Q1 | -8.31 Million USD | 19.17% |
| 2020 Q1 | -11.33 Million USD | 23.37% |
| 2020 FY | -52.17 Million USD | -53.81% |
| 2020 Q3 | -11.4 Million USD | 40.58% |
| 2020 Q2 | -19.18 Million USD | -69.28% |
| 2020 Q4 | -10.29 Million USD | 9.73% |
| 2019 FY | -33.92 Million USD | -96.63% |
| 2019 Q1 | -5.86 Million USD | -3.04% |
| 2019 Q2 | -7.94 Million USD | -35.44% |
| 2019 Q3 | -5.44 Million USD | 31.53% |
| 2019 Q4 | -14.79 Million USD | -171.74% |
| 2018 FY | -17.25 Million USD | -35.88% |
| 2018 Q4 | -5.69 Million USD | -80.79% |
| 2018 Q3 | -3.15 Million USD | 45.36% |
| 2018 Q2 | -5.76 Million USD | -118.68% |
| 2018 Q1 | -2.63 Million USD | 41.97% |
| 2017 Q1 | -3.27 Million USD | -138.05% |
| 2017 FY | -12.69 Million USD | -9.57% |
| 2017 Q3 | -1.8 Million USD | 41.51% |
| 2017 Q4 | -4.54 Million USD | -152.37% |
| 2017 Q2 | -3.07 Million USD | 5.93% |
| 2016 Q1 | -2.58 Million USD | -27.56% |
| 2016 Q4 | -1.37 Million USD | 10.56% |
| 2016 Q3 | -1.53 Million USD | 74.77% |
| 2016 Q2 | -6.09 Million USD | -135.87% |
| 2016 FY | -11.58 Million USD | -22.47% |
| 2015 Q2 | -4.76 Million USD | -55.96% |
| 2015 FY | -9.46 Million USD | -11.67% |
| 2015 Q1 | -3.05 Million USD | -17.05% |
| 2015 Q4 | -2.02 Million USD | -636.14% |
| 2015 Q3 | 377.66 Thousand USD | 107.93% |
| 2014 Q4 | -2.6 Million USD | 34.13% |
| 2014 FY | -8.47 Million USD | 13.58% |
| 2014 Q1 | -1.11 Million USD | 32.7% |
| 2014 Q2 | -787.21 Thousand USD | 29.56% |
| 2014 Q3 | -3.96 Million USD | -403.04% |
| 2013 Q1 | -3.76 Million USD | -334.9% |
| 2013 FY | -9.8 Million USD | -295.83% |
| 2013 Q3 | -2.59 Million USD | -41.04% |
| 2013 Q2 | -1.83 Million USD | 51.11% |
| 2013 Q4 | -1.66 Million USD | 36.0% |
| 2012 FY | -2.47 Million USD | 0.0% |
| 2012 Q4 | -865.15 Thousand USD | -26.11% |
| 2012 Q3 | -686.04 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 52.869% |
| BrainsWay Ltd. | -4.19 Million USD | -591.947% |
| Cerus Corporation | -37.48 Million USD | 22.535% |
| Envoy Medical, Inc. | -29.9 Million USD | 2.899% |
| electroCore, Inc. | -18.83 Million USD | -54.195% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -228.147% |
| IceCure Medical Ltd | -14.65 Million USD | -98.205% |
| Inogen, Inc. | -102.44 Million USD | 71.653% |
| OrthoPediatrics Corp. | -20.97 Million USD | -38.462% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 44.858% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -111.281% |
| MaxCyte, Inc. | -37.92 Million USD | 23.421% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -144.876% |
| Nexalin Technology, Inc. | -4.64 Million USD | -524.711% |
| Orthofix Medical Inc. | -151.39 Million USD | 80.818% |
| PAVmed Inc | -64.17 Million USD | 54.747% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 44.649% |
| RxSight, Inc. | -48.6 Million USD | 40.255% |
| Sight Sciences, Inc. | -55.54 Million USD | 47.718% |
| SI-BONE, Inc. | -43.33 Million USD | 32.986% |
| TELA Bio, Inc. | -46.66 Million USD | 37.766% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 41.363% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -113.804% |
| Acutus Medical, Inc. | -81.66 Million USD | 64.438% |
| Talis Biomedical Corporation | -62 Million USD | 53.165% |
| Spectral AI, Inc. | -20.85 Million USD | -39.259% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 52.216% |
| CVRx, Inc. | -41.19 Million USD | 29.51% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 4636.267% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -165.086% |
| Bioventus Inc. | -156.23 Million USD | 81.411% |
| Venus Concept Inc. | -37.25 Million USD | 22.038% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 50.81% |
| LivaNova PLC | 17.54 Million USD | 265.514% |
| 908 Devices Inc. | -36.39 Million USD | 20.215% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 84.44% |
| Nemaura Medical Inc. | -14.14 Million USD | -105.328% |
| NeuroPace, Inc. | -32.95 Million USD | 11.879% |
| LENSAR, Inc. | -14.38 Million USD | -101.912% |
| Apyx Medical Corporation | -18.71 Million USD | -55.192% |
| Cutera, Inc. | -162.83 Million USD | 82.165% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -168.153% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 64.87% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -31.473% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 142.871% |
| Axonics, Inc. | -6.08 Million USD | -377.02% |
| Outset Medical, Inc. | -172.79 Million USD | 83.194% |
| IRIDEX Corporation | -9.57 Million USD | -203.459% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 72.576% |
| IRadimed Corporation | 17.19 Million USD | 268.914% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -252.268% |
| INVO Bioscience, Inc. | -8.03 Million USD | -261.449% |
| Telesis Bio, Inc. | -47.72 Million USD | 39.148% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 383.52% |
| Varex Imaging Corporation | -47.7 Million USD | 39.117% |
| Quipt Home Medical Corp. | -2.78 Million USD | -943.139% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -157.319% |
| Pulmonx Corporation | -60.84 Million USD | 52.269% |
| Dynatronics Corporation | -2.69 Million USD | -976.502% |
| Modular Medical, Inc. | -17.47 Million USD | -66.234% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -155.036% |
| Semler Scientific, Inc. | 20.58 Million USD | 241.092% |
| InMode Ltd. | 197.91 Million USD | 114.673% |
| Bruker Corporation | 427.2 Million USD | 106.798% |
| Cytosorbents Corporation | -28.5 Million USD | -1.872% |
| DexCom, Inc. | 541.5 Million USD | 105.363% |
| Align Technology, Inc. | 445.05 Million USD | 106.525% |
| Viveve Medical, Inc. | -22.02 Million USD | -31.843% |
| ZimVie Inc. | -393.28 Million USD | 92.616% |
| Movano Inc. | -29.28 Million USD | 0.826% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -139.06% |
| Nexalin Technology, Inc. | -4.64 Million USD | -524.711% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 4636.267% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 86.954% |
| Profound Medical Corp. | -28.56 Million USD | -1.652% |
| Insulet Corporation | 206.3 Million USD | 114.077% |
| enVVeno Medical Corporation | -23.51 Million USD | -23.495% |
| Surmodics, Inc. | -11.54 Million USD | -151.612% |
| iCAD, Inc. | -4.84 Million USD | -499.154% |
| Nuwellis, Inc. | -20.2 Million USD | -43.703% |
| Biotricity, Inc. | -14.09 Million USD | -106.048% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 76.467% |
| Aethlon Medical, Inc. | -12.2 Million USD | -137.882% |
| InspireMD, Inc. | -19.91 Million USD | -45.817% |
| PAVmed Inc. | -64.17 Million USD | 54.747% |
| BIOLASE, Inc. | -20.63 Million USD | -40.757% |
| Beyond Air, Inc. | -60.24 Million USD | 51.793% |
| FONAR Corporation | 10.56 Million USD | 374.817% |
| AxoGen, Inc. | -21.71 Million USD | -33.731% |
| Vivani Medical, Inc. | -25.65 Million USD | -13.211% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 201.845% |
| Inari Medical, Inc. | -1.63 Million USD | -1675.122% |
| UFP Technologies, Inc. | 44.92 Million USD | 164.645% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -465.844% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -339.668% |
| Tenon Medical, Inc. | -15.58 Million USD | -86.387% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -88.26% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 17.807% |
| AdaptHealth Corp. | -678.89 Million USD | 95.722% |
| Sintx Technologies, Inc. | -8.25 Million USD | -251.629% |
| NanoVibronix, Inc. | -3.71 Million USD | -682.565% |
| Quanterix Corporation | -32.33 Million USD | 10.184% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -157.319% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 6087.835% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 90.532% |
| TransMedics Group, Inc. | -25.02 Million USD | -16.034% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -31.211% |
| NeuroMetrix, Inc. | -6.52 Million USD | -344.767% |
| Hyperfine, Inc. | -44.23 Million USD | 34.353% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 63.006% |
| Biomerica, Inc. | -5.97 Million USD | -385.798% |
| Bone Biologics Corporation | -8.94 Million USD | -224.526% |
| AVITA Medical, Inc. | -39.16 Million USD | 25.856% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -191.755% |
| Silk Road Medical, Inc | -55.74 Million USD | 47.902% |